Financial Wire

Wells Fargo Downgrades Soleno Therapeutics to Equal Weight From Overweight, Adjusts PT to $53 From $110

-- Soleno Therapeutics Inc (SLNO) has an average rating of Hold and mean price target of $59.33, according to analysts polled by FactSet.

(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

Related Articles